Does PANITUMUMAB Cause Interstitial lung disease? 233 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 233 reports of Interstitial lung disease have been filed in association with PANITUMUMAB (Vectibix). This represents 2.1% of all adverse event reports for PANITUMUMAB.
233
Reports of Interstitial lung disease with PANITUMUMAB
2.1%
of all PANITUMUMAB reports
139
Deaths
137
Hospitalizations
How Dangerous Is Interstitial lung disease From PANITUMUMAB?
Of the 233 reports, 139 (59.7%) resulted in death, 137 (58.8%) required hospitalization, and 44 (18.9%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for PANITUMUMAB.
What Other Side Effects Does PANITUMUMAB Cause?
Rash (1,392)
Diarrhoea (1,123)
Death (767)
Dermatitis acneiform (758)
Neutropenia (757)
Skin toxicity (728)
Neuropathy peripheral (613)
Hypomagnesaemia (611)
Nausea (608)
Disease progression (600)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which PANITUMUMAB Alternatives Have Lower Interstitial lung disease Risk?
PANITUMUMAB vs PANOBINOSTAT
PANITUMUMAB vs PANTOPRAZOLE
PANITUMUMAB vs PANTOPRAZOLE ANHYDROUS
PANITUMUMAB vs PANTOTHENIC ACID
PANITUMUMAB vs PAPAVERINE